SCHEMBL29705715

SCHEMBL29705715

C[C@H](NC(=O)C1(c2cccc(OCc3ccccc3)c2)CCOCC1)c1ccc(C(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ ACACB O00763 3/20 0.48
▸ TP53 P04637 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ ALOX5 P09917 3/20 0.46
▸ TSHR P16473 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SRD5A2 P31213 1/20 0.45
▸ RXRA P19793 2/20 0.44
▸ RXRB P28702 2/20 0.44
▸ NR4A2 P43354 2/20 0.44
▸ RXRG P48443 1/20 0.43
▸ ACACA Q13085 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ PTGER4 P35408 1/20 0.42
▸ NR4A1 P22736 1/20 0.41
▸ NR4A3 Q92570 1/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23164192 1.00 ALDH1A1 (0.48) ALDH1A1ACACBTP53HTTALOX5
SCHEMBL23164193 1.00 ALDH1A1 (0.48) ALDH1A1ACACBTP53HTTALOX5
SCHEMBL23164208 0.93 ALOX5 (0.47) ALDH1A1ACACBTP53HTTALOX5
SCHEMBL23164209 0.93 ALOX5 (0.47) ALDH1A1ACACBTP53HTTALOX5
SCHEMBL23164044 0.92 ACACB (0.50) ACACBTSHRSMN1; SMN2SRD5A2RXRA
SCHEMBL23164048 0.92 ACACB (0.50) ACACBTSHRSMN1; SMN2SRD5A2RXRA
SCHEMBL23163958 0.90 RXRA (0.52) ALDH1A1ACACBTP53HTTSMN1; SMN2
SCHEMBL23163961 0.90 RXRA (0.52) ALDH1A1ACACBTP53HTTSMN1; SMN2
SCHEMBL28749473 0.88 ALDH1A1 (0.46) ALDH1A1TP53HTTALOX5SMN1; SMN2
SCHEMBL29705535 0.88 ALDH1A1 (0.46) ALDH1A1TP53HTTALOX5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114555573-A Prostaglandin E2(PGE2)EP4Receptor antagonists 多曼治疗学公司 2022-05-27 — — CN disclosed
Send feedback